作者：
Catharine I,Paules [1]
;
Jacqueline A,Nordwall [2]
;
Kathryn,Shaw-Saliba [3]
;
Judith A,Aberg [4]
;
Edward M,Gardner [5]
;
Anna L,Goodman [6]
;
N,Kumarasamy [7]
;
Shikha,Vasudeva [8]
;
David M,Vock [2]
;
Crystal M,North [9]
;
Jens,Lundgren [10]
;
Neil R,Aggarwal [11]
;
STRIVE Network and TICO Trial Study Group
作者单位：
Division of Infectious Diseases, Penn State Health Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA, 17033, USA. cpaules@pennstatehealth.psu.edu.
[1]
Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
[2]
Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
[3]
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
[4]
Denver Health and Hospital, Authority, Denver, CO, USA.
[5]
MRC Clinical Trials Unit at University College London and CIDR, King's College London and Guy's and St. Thomas' NHS Foundation Trust, London, UK.
[6]
VHS Infectious Diseases Medical Centre, CART Clinical Research Site, Voluntary Health Services, Chennai, India.
[7]
Division of Infectious Diseases, VA Medical Center, Salem, VA, USA.
[8]
Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.;Harvard Medical School, Boston, MA, USA.
[9]
CHIP Center of Excellence for Health, Immunity, and Infections, Department of Infectious Diseases, University of Copenhagen, Righospitalet, Copenhagen, Denmark.
[10]
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
[11]
DOI
10.1186/s12879-024-10428-7
PMID
39810077
发布时间
2025-01-14
换一批
换一批
